Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logo brought to you by Benzinga Data
$0.489800
-0.05-9.30%
At close: -
$0.489300
-0.0005-0.10%
After Hours: 5:14 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
Journey Therapeutics, Inc announced it will be merged with Entero Therapeutics (ENTO) on Wednesday, November 13, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Entero Therapeutics (ENTO)?

A

There have been no specific sales or earnings guidance reported for Entero Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch